为有效规避和防范汇率大幅波动对杭州豪悦护理用品股份有限公司（ 以下简称"公司"）经营造成的不利影响，降低外汇风险，增强公司财务稳健 性，在保证日常运营资金需求的情况下，公司及其合并报表范围内下属子公 司（以下简称"子公司"）拟与境内商业银行开展额度不超过2,500万美元的 外汇套期保值业务，交易品种包括但不限于远期业务、掉期业务、互换业务、 期权业务及其他外汇衍生产品业务。额度有效期为自第三届董事会第十六次 会议审议通过之日起十二个月内。 已履行的审议程序：本次开展外汇套期保值业务已经公司第三届董事 会第十六次会议审议通过，无需提交股东大会审议。 特别风险提示：公司进行外汇套期保值业务遵循合法、审慎、安全、 有效、稳健原则，不进行以投机为目的的外汇交易，所有外汇套期保值业务均 以正常生产经营为基础。本次外汇套期保值业务存在一定的汇率波动风险、履 约风险、操作风险等风险,敬请广大投资者注意投资风险。 一、外汇套期保值情况概述 （一）外汇套期保值目的 证券代码:605009 证券简称:豪悦护理 公告编号：2025-042 杭州豪悦护理用品股份有限公司 关于开展外汇套期保值业务的公告 本公司董事会及全体董事保证本公 ...

证券代码：605009 证券简称：豪悦护理 公告编号：2025-047 杭州豪悦护理用品股份有限公司 关于为子公司提供担保进展的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●对外担保逾期的累计数量：无 一、担保情况概述 （一）担保情况概述 近日，公司与招商银行武汉分行签署了《最高额不可撤销担保书》，在保 证责任期间内，为丝宝护理提供 5,000 万元的连带责任保证担保；公司与招商 银行杭州分行签署了《最高额不可撤销担保书》，在保证责任期间内，为伊蓓 佳提供 10,000 万元的连带责任保证担保；公司与招商银行杭州分行续签了《最 高额不可撤销担保书》，在保证责任期间内，为湖北豪悦提供 6,000 万元的连 带责任保证担保；公司与招商银行武汉分行续签了《最高额不可撤销担保书》， 在保证责任期间内，为湖北豪悦提供 4,000 万元的连带责任保证担保；公司与 宁波银行杭州分行续签了《最高额保证合同》，在保证责任期间内，为江苏豪 悦提供 5,000 万元的连带责任保证担保。 （二）本次担保事项履行的决策程序 公 ...

Core Viewpoint - The company, HaoYue Care (605009.SH), plans to establish a production base in Peru through its subsidiary Nantong Bailian Nursing Products Co., Ltd. and Jiangsu Haoyue Industrial Co., Ltd. with a total investment not exceeding $35 million [1] Investment Details - The investment will be split with Nantong Bailian contributing 99% and Jiangsu Haoyue contributing 1% [1] - The funds will be used for setting up and operating the overseas company, purchasing land, constructing facilities, procuring equipment, and covering working capital [1]

Group 1 - The core viewpoint of the article is that Haoyue Care (605009.SH) has decided to suspend its investment in the Mexican production base project due to the significant impact of repeated tariff measures imposed by the U.S. on Mexico's economy and the uncertainty in U.S.-Mexico relations [1] - The company believes that the feasibility and necessity of the original investment project have undergone substantial changes, prompting a reassessment of resource allocation to ensure the successful achievement of strategic goals [1] - The company plans to make further decisions regarding the investment project after the situation between the U.S. and Mexico stabilizes [1]

Market Overview - The personal care products sector experienced a decline of 3.06% on August 27, with Yanjiang Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 3800.35, down 1.76%, while the Shenzhen Component Index closed at 12295.07, down 1.43% [1] Stock Performance - Notable stock performances include: - Yiyi Co., Ltd. (001206) closed at 24.93, up 0.56% with a trading volume of 59,600 shares [1] - Beijia Co., Ltd. (603059) closed at 31.23, down 1.39% with a trading volume of 25,300 shares [1] - Stable Medical (300888) closed at 40.95, down 2.27% with a trading volume of 109,700 shares [1] - Zhongshun Jierou (002511) closed at 8.55, down 4.26% with a trading volume of 253,900 shares [1] Capital Flow - The personal care products sector saw a net outflow of 94.86 million yuan from institutional investors, while retail investors had a net inflow of 86.75 million yuan [2] - The capital flow for individual stocks indicates: - Yiyi Co., Ltd. had a net inflow of 22.41 million yuan from institutional investors [3] - Yanjiang Co., Ltd. experienced a net outflow of 5.38 million yuan from institutional investors [3] - Zhongshun Jierou had a net inflow of 17.37 million yuan from retail investors despite a net outflow from institutional investors [3]

从资金流向上来看，当日个护用品板块主力资金净流出1.23亿元，游资资金净流入6237.06万元，散户资 金净流入6093.09万元。个护用品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入(元) | | 游资净占比 散户净流入(元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603193 润本股份 | | 1507.21万 | 7.79% | -598.44万 | -3.09% | -908.77万 | -4.70% | | 600249 | 两面针 | 93.40万 | 0.88% | 43.79万 | 0.41% | -137.19万 | -1.30% | | 300658 延江股份 | | -113.98万 | -1.79% | -328.93万 | -5.16% | 442.92万 | 6.95% | | 001328 登康口腔 | | -505.40万 | -5.81% | 174.29万 | 2.00% | 331.10万 | 3.81% | | 603059 倍加洁 ...

Market Overview - The personal care products sector increased by 0.74% on August 21, with Jieya Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Stock Performance - Jieya Co., Ltd. (301108) closed at 30.18, up 10.23% with a trading volume of 73,200 shares and a turnover of 219 million yuan [1] - Yiyi Co., Ltd. (001206) closed at 27.01, up 3.17% with a trading volume of 99,000 shares and a turnover of 265 million yuan [1] - Zhongshun Jierou (002511) closed at 8.91, up 2.65% with a trading volume of 450,700 shares and a turnover of 403 million yuan [1] - Other notable performances include: - Liangmian Needle (600249) up 1.36% - Beijia Clean (603059) up 1.13% - Wanjian Medical (300888) up 0.62% [1] Capital Flow - The personal care products sector experienced a net outflow of 42.6484 million yuan from institutional investors, while retail investors saw a net inflow of 67.9388 million yuan [2] - The detailed capital flow for key stocks shows: - Wanjian Medical had a net inflow of 23.3464 million yuan from institutional investors [3] - Jieya Co., Ltd. had a net inflow of 9.9211 million yuan from institutional investors [3] - Zhongshun Jierou had a net inflow of 1.121 million yuan from retail investors [3]

Group 1 - Jiangyin Market Supervision Bureau conducted quality supervision and sampling inspections on 16 categories of products, including fertilizers, daily plastic products, children's clothing, and safety helmets in Q2 2025 [2] - The inspection results for baby diapers and pads showed that several products passed the quality checks, indicating compliance with safety and quality standards [2][3] - The report includes detailed information about the sampled products, including the names of manufacturers, product specifications, and inspection dates [2] Group 2 - The inspection covered various brands and manufacturers, such as Lule Health Technology Co., Fujian Hengan Group, and others, highlighting the diversity in the market [2] - Specific products like the "Luan Shi Day and Night Baby Diapers" and "Qimo Baby Diapers" were among those tested, with results indicating they met quality standards [2] - The report emphasizes the importance of quality supervision in ensuring consumer safety and maintaining market integrity [2]

Core Viewpoint - The article investigates the challenges faced by Haipaike, a maternal and infant e-commerce platform preparing for an IPO, particularly focusing on allegations of counterfeit products and questionable supplier management practices [1][2][3]. Group 1: Company Overview - Haipaike, founded in 2015, is a B2B platform targeting the lower-tier market for maternal and infant products, connecting suppliers with retail stores and expanding into beauty and health products [2][3]. - The company claims to have a market share of 10.1% in the family care and nutrition product sector, with a projected transaction volume of 8.6 billion yuan in 2024 [2]. Group 2: Counterfeit Product Allegations - Haipaike has faced ongoing allegations of selling counterfeit products, with consumer complaints documented on third-party platforms [2][3]. - A test conducted by a journalist revealed that a purchased product, claimed to be genuine, failed authenticity checks, raising concerns about the company's product verification processes [3][5]. Group 3: Supplier Management Issues - The investigation highlighted significant issues in Haipaike's supplier management, including the presence of unauthorized products on the platform and a lack of rigorous supplier vetting [4][6]. - The company’s customer service has struggled to address counterfeit claims effectively, often leading to consumer dissatisfaction and difficulties in obtaining refunds [5][7]. Group 4: Operational Metrics and Claims - Haipaike claims to connect approximately 290,000 retail stores, but the authenticity of this figure is questioned, as the registration process for stores appears to be lax [10][11]. - The company’s revenue model has shifted from commission-based income to self-operated sales, with a notable decline in commission revenue from 354 million yuan in 2022 to 229 million yuan in 2024 [13][14]. Group 5: Financial Performance and Future Outlook - Haipaike's revenue showed signs of decline, with figures of 895 million yuan in 2022, 1.067 billion yuan in 2023, and 1.032 billion yuan in 2024, alongside a cumulative loss of 1.854 billion yuan by the end of 2024 [15][16]. - The company has undergone multiple rounds of financing, with significant shareholder withdrawals, indicating potential instability as it approaches its IPO [15][16].

Core Insights - The article highlights the challenges faced by Haipai Ke, a maternal and infant e-commerce platform, including allegations of counterfeit products and declining growth, as it prepares for its IPO [1][11]. Company Overview - Haipai Ke, founded in 2015, focuses on the lower-tier market for maternal and infant products, connecting suppliers with retail stores and expanding into beauty and health products [1][9]. - The company claims a market share of 10.1% in the family care and nutrition product sector, with a projected transaction volume of 8.6 billion yuan in 2024 [1]. Counterfeit Allegations - The company has faced ongoing allegations of selling counterfeit products, with consumer complaints documented on third-party platforms [1][6]. - A specific case involved a purchase of Estee Lauder's product, which was later confirmed as counterfeit by a professional testing agency [2][4]. Supplier Management Issues - The investigation revealed significant issues in supplier management, with unauthorized products being listed on the platform [4][6]. - The company’s customer service has offered refunds and compensation for counterfeit claims, but enforcement against suppliers remains weak [4][6]. Retail Network Authenticity - Haipai Ke claims to connect approximately 290,000 retail stores, but the authenticity of this figure is questioned, as the registration process for stores appears to be lax [7][8]. - Reports indicate that individuals can easily register as retail stores without stringent verification, undermining the claimed network size [8]. Financial Performance - The company has experienced revenue fluctuations, with reported revenues of 895 million yuan in 2022, 1.067 billion yuan in 2023, and a decline to 1.032 billion yuan in 2024 [11]. - Despite a shift towards profitability, the company has accumulated losses of 1.854 billion yuan by the end of 2024 [11][12]. Investment and Shareholder Dynamics - Haipai Ke has undergone multiple rounds of financing, with significant investments from various firms, but has also seen several shareholders withdraw their investments [11][12]. - The company is under pressure to complete its IPO by the end of 2026, with potential consequences for failing to do so, including issuing new convertible notes [12].